paclitaxel has been researched along with Kidney Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arany, I; Clark, JS; Ember, I; Juncos, LA; Reed, D; Szabó, I | 1 |
| Han, JS; Heo, NJ; Joo, KW; Jung, ES; Kim, DK; Kim, S; Lee, J | 1 |
| Bodnar, L; Gasowska-Bodnar, A; Synowiec, A; Szarlej-Wcisło, K; Szczylik, C; Wcislo, G | 1 |
| Dreicer, R; Levitt, R; Manola, J; See, W; Vaughn, DJ; Wilding, G | 1 |
| Ebuchi, M; Hasegawa, K; Koide, A; Maruyama, M; Maruyama, S; Miyawaki, Y; Ohbu, M; Takashima, I; Tamura, N | 1 |
| Bajorin, DF; Boyle, MG; Galsky, MD; Iasonos, A; Mironov, S; Scattergood, J | 1 |
| Davidson, SA; Merouani, A; Schrier, RW | 1 |
| Anagnostopoulos, A; Athanassiades, P; Deliveliotis, C; Dimopoulos, C; Dimopoulos, MA; Mitropoulos, D; Moulopoulos, LA; Papadimitriou, C | 1 |
| Clarke, SJ; Rivory, LP | 1 |
| De Giorgi, U; Marangolo, M; Papiani, G; Rosti, G | 1 |
2 review(s) available for paclitaxel and Kidney Diseases
| Article | Year |
|---|---|
Clinical pharmacokinetics of docetaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Child; Clinical Trials as Topic; Docetaxel; Drug Interactions; Forecasting; Humans; Kidney Diseases; Liver Diseases; Paclitaxel; Protein Binding; Taxoids | 1999 |
The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Etoposide; Europe; Forecasting; Gastrointestinal Diseases; Germinoma; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Ifosfamide; Kidney Diseases; Male; Multicenter Studies as Topic; Neoplasms, Second Primary; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Salvage Therapy; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2002 |
4 trial(s) available for paclitaxel and Kidney Diseases
| Article | Year |
|---|---|
Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: a randomised phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Double-Blind Method; Female; Humans; Kidney Diseases; Magnesium; Magnesium Sulfate; Middle Aged; Ovarian Neoplasms; Paclitaxel; Renal Agents | 2008 |
Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896): a trial of the Eastern Cooperative Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Paclitaxel; Prognosis; Survival Analysis; Urinary Bladder Neoplasms | 2002 |
Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cohort Studies; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Gemcitabine; Humans; Kidney Diseases; Male; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Survival Rate; Urinary Bladder Neoplasms | 2007 |
Treatment of patients with metastatic urothelial carcinoma and impaired renal function with single-agent docetaxel.
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Transitional Cell; Docetaxel; Female; Humans; Kidney Diseases; Male; Middle Aged; Paclitaxel; Taxoids | 1998 |
4 other study(ies) available for paclitaxel and Kidney Diseases
| Article | Year |
|---|---|
The role of p66shc in taxol- and dichloroacetic acid-dependent renal toxicity.
Topics: Animals; Cytochromes c; Dichloroacetic Acid; Gene Knockdown Techniques; Kidney Diseases; Kidney Tubules, Proximal; Membrane Potential, Mitochondrial; Mice; Mitochondria; Paclitaxel; Phosphorylation; Phosphoserine; Protein Binding; Reactive Oxygen Species; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1 | 2013 |
Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Matrix Proteins; Fibrosis; Kidney; Kidney Diseases; Male; Mitogen-Activated Protein Kinases; Paclitaxel; Plasminogen Activator Inhibitor 1; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Smad3 Protein; Time Factors; Transforming Growth Factor beta1; Tubulin Modulators; Ureteral Obstruction | 2016 |
[A case of intraperitoneal paclitaxel administration in a gastric cancer patient with severely impaired renal function].
Topics: Antineoplastic Agents, Phytogenic; Ascites; Female; Humans; Infusions, Parenteral; Kidney Diseases; Middle Aged; Paclitaxel; Stomach Neoplasms | 2005 |
Increased nephrotoxicity of combination taxol and cisplatin chemotherapy in gynecologic cancers as compared to cisplatin alone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cisplatin; Female; Genital Neoplasms, Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Middle Aged; Paclitaxel; Retrospective Studies | 1997 |